Further dysregulation of AQP4 may be occurring in neurodegeneration (AD and frontotemporal dementia (FTD)), given a higher presence of AQP4 in the cerebrospinal fluid (CSF) [43]. This evidence concerns the gene AQP4 and Alzheimer disease.